The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients

Nutrition in Clinical Practice

Volumn 26, Issue 4, 2011, Pages 463-473

  Wiese, Dawn M ^a   Lashner, Bret A ^b   Lerner, Edith ^c   Demichele, Stephen J ^d   Seidner, Douglas L ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Crohn's disease; enteral nutrition; fatty acids; fish oils; gastroenterology; prebiotics

Indexed keywords

25 HYDROXYVITAMIN D; ANTIOXIDANT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; FRUCTOSE OLIGOSACCHARIDE; GUM ARABIC; ICOSAPENTAENOIC ACID; PHOSPHOLIPID; PREBIOTIC AGENT; TRACE ELEMENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE NUTRITION FORMULA; MALE; NUTRITIONAL STATUS; OPEN STUDY; PATIENT COMPLIANCE; PHOSPHOLIPID BLOOD LEVEL; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; UNITED STATES; VITAMIN BLOOD LEVEL;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ADULT; AGED; ANTIOXIDANTS; ARACHIDONIC ACID; BODY FLUID COMPARTMENTS; CROHN DISEASE; DIETARY FIBER; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PHOSPHOLIPIDS; PILOT PROJECTS; PREBIOTICS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VITAMIN D; YOUNG ADULT;

EID: 79960667983     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611413778     Document Type: Article

References (51)

1. Buchman A, Scolapio J Clinical Nutrition in Gastrointestinal Disease. Buchman A, ed. Thorofare, NJ: SLACK ; 2006: 225-232.
2. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr. 1998 ; 67: 919-926 (Pubitemid 28196667)
3. Goh J, O'Morain CA. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther. 2003 ; 17: 307-320 (Pubitemid 36259393)
4. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995 ; 108: 1056-1067
5. King T. Meta-analysis of enteral nutrition as a primarytreatment of active Crohn's disease. Clin Nutr. 1995 ; 14: 388-389
6. Fernandez-Banares F, Cabre E, Gonzalez-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut. 1994 ; 35: S55 - S59
7. Griffiths AM. Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr. 2005 ; 29: S108 - S112
8. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 ; 83: 1505S - 1519S (Pubitemid 44713092)
9. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 ; 334: 1557-1560 (Pubitemid 26177482)
10. Lee S, Gura KM, Kim S, Arsenault DA, Bistrian BR, Puder M. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006 ; 21: 323-341
11. Teitelbaum JE, Allan Walker W. Review: the role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem. 2001 ; 12: 21-32 (Pubitemid 32120193)
12. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut. 1990 ; 31: 539-544 (Pubitemid 20185956)
13. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol. 1995 ; 30 (suppl 8). 98-101
14. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr. 2004 ; 23: 71-78 (Pubitemid 38200837)
15. Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol. 2007 ; 102: 2016-2025 (Pubitemid 47301536)
16. Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn's disease: the EPIC Randomized Controlled Trials. JAMA. 2008 ; 299: 1690-1697 (Pubitemid 351519866)
17. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol. 2002 ; 37 (suppl 14). 67-72 (Pubitemid 35385930)
18. Videla S, Vilaseca J, Antolin M, et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol. 2001 ; 96: 1486-1493 (Pubitemid 32455079)
19. Galvez J, Rodriguez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res. 2005 ; 49: 601-608 (Pubitemid 40853706)
20. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004 ; 113: 427-437 (Pubitemid 39593361)
21. Steinhart A, Brzezinski A, Baker J. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol. 1994 ; 89: 179-183 (Pubitemid 24054175)
22. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet. 1994 ; 344: 859-861 (Pubitemid 24290387)
23. Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci. 2008 ; 53: 2208-2214
24. Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Aliment Pharmacol Ther. 2002 ; 16: 1997-2015 (Pubitemid 36009163)
25. Seidner DL, Lashner BA, Brzezinski A, et al. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005 ; 3: 358-369 (Pubitemid 40488344)
26. Huang Y, Chaudhary S, Thurmond J, et al. Cloning of delta12- and delta6-desaturases from Mortierella alpina and recombinant production of gamma-linolenic acid in Saccharomyces cerevisiae. Lipids. 1999 ; 34: 649-659 (Pubitemid 29381833)
27. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 ; 70: 439-444
28. Denis M, Reenaers C, Fontaine F, Belaïche J, Louis E. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm Bowel Dis. 2007 ; 13: 1100-1105 (Pubitemid 47402593)
29. Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008 ; 57: 1518-1523
30. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos G. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008 ; 103: 162-169
31. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994 ; 106: 287-296 (Pubitemid 24041204)
32. Wiese D, Lashner B, Seidner D. Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy. Nutr Clin Pract. 2008 ; 23: 551-556
33. Romanato G, Scarpa M, Angriman I, et al. Plasma lipids and inflammation in active inflammatory bowel diseases. Aliment Pharmacol Ther. 2009 ; 29: 298-307
34. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007 ; ( 1 ):
35. Heuschkel R, Menache C, Megerian J, Baird A. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000 ; 31: 8-15 (Pubitemid 30456568)
36. Escher J, Taminiau J. Treatment of inflammatory bowel disease in childhood. Scand J Gastroenterol Suppl. 2001 ; (234). 48-50 (Pubitemid 33070911)
37. Sousa Guerreiro C, Cravo M, Costa AR, et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol. 2007 ; 102: 2551-2556 (Pubitemid 47631772)
38. Filippi J, Al-Jaouni R, Wiroth JB, Hebuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006 ; 12: 185-191
39. Valentini L, Schaper L, Buning C, et al. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition. 2008 ; 24: 694-702
40. Barber M, Ross J, Voss A, Tisdale M, Fearon K. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999 ; 81: 80-86 (Pubitemid 29415495)
41. Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol. 2006 ; 12: 5941-5950 (Pubitemid 44608471)
42. Siffledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis. 2004 ; 10: 220-228 (Pubitemid 38618250)
43. van Hogezand RA, Hamdy NA. Skeletal morbidity in inflammatory bowel disease. Scand J Gastroenterol Suppl. 2006 ; (243). 59-64 (Pubitemid 43941067)
44. Bartels LE, Jorgensen SP, Agnholt J, Kelsen J, Hvas CL, Dahlerup JF. 1,25-Dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol. 2007 ; 7: 1755-1764 (Pubitemid 350046440)
45. Stio M, Martinesi M, Bruni S, et al. The vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol. 2007 ; 103: 51-60 (Pubitemid 44821819)
46. Zhao Y, Shao L, Teng L, et al. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure. J Int Med Res. 2009 ; 37: 1831-1841
47. Rudkowska I, Marcotte B, Pilon G, Lavigne C, Marette A, Vohl M. Fish nutrients decrease expression levels of tumor necrosis factor-alpha in cultured human macrophages. Physiol Genomics. 2010 ; 40: 189-194
48. Buckley J, Howe P. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev. 2009 ; 10: 648-659
49. Pérez-Matute P, Pérez-Echarri N, Martínez J, Marti A, Moreno-Aliaga M. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr. 2007 ; 97: 389-398 (Pubitemid 46671814)
50. Zahn A, Hinz U, Karner M, Ehehalt R, Stremmel W. Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis. Inflamm Bowel Dis. 2006 ; 12: 1058-1067 (Pubitemid 44665476)
51. Mitchell A, Guyatt G, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988 ; 10: 306-310